Insights

Growing Market Presence Infervision has established a strong global footprint with partnerships across over 1000 top hospitals worldwide, indicating broad adoption of its AI-driven medical solutions and significant opportunities for expanding into new markets and healthcare networks.

Innovative AI Portfolio With specialized modules for disease detection, interventional support, patient management, and research, Infervision offers a comprehensive suite of AI solutions that can be tailored to address a wide range of clinical needs, opening multiple avenues for upselling and cross-selling to healthcare providers.

Strategic Financial Position Having secured $140 million in funding and achieved revenue between 10 to 25 million dollars, Infervision is financially positioned for growth, making it a suitable partner for collaborations and new product integrations within healthcare institutions seeking advanced AI innovations.

Recent Product Launches The launch of the InferRead Pneumonia COVID-19 screening system demonstrates Infervision’s ability to swiftly develop and deploy targeted solutions during health crises, highlighting opportunities to introduce new AI tools for emerging healthcare challenges and disease areas.

Partnership and Expansion Collaborations with significant institutions like Sanford Research and Thynk Health, along with recent investments from Goldman Sachs, position Infervision as a trusted partner for large healthcare systems and investors, providing avenues for joint ventures, research collaborations, and enterprise-level sales engagements.

Infervision Tech Stack

Infervision uses 8 technology products and services including Sensors Data, Amazon CloudFront, Google Fonts API, and more. Explore Infervision's tech stack below.

  • Sensors Data
    Analytics
  • Amazon CloudFront
    Content Delivery Network
  • Google Fonts API
    Font Scripts
  • Snap.svg
    Javascript Libraries
  • OWL Carousel
    Javascript Libraries
  • Webflow
    Page Builders
  • HSTS
    Security
  • OpenResty
    Web Servers

Media & News

Infervision's Email Address Formats

Infervision uses at least 2 format(s):
Infervision Email FormatsExamplePercentage
LFirst@infervision.comDJohn@infervision.com
33%
FirstLast@infervision.comJohnDoe@infervision.com
22%
First.Last@infervision.comJohn.Doe@infervision.com
23%
First_Last@infervision.comJohn_Doe@infervision.com
22%

Frequently Asked Questions

Where is Infervision's headquarters located?

Minus sign iconPlus sign icon
Infervision's main headquarters is located at 1099 Wall Street West Lyndhurst, New Jersey 07071 United States. The company has employees across 3 continents, including AsiaNorth AmericaEurope.

What is Infervision's official website and social media links?

Minus sign iconPlus sign icon
Infervision's official website is global.infervision.com and has social profiles on LinkedInCrunchbase.

What is Infervision's NAICS code?

Minus sign iconPlus sign icon
Infervision's NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does Infervision have currently?

Minus sign iconPlus sign icon
As of April 2026, Infervision has approximately 73 employees across 3 continents, including AsiaNorth AmericaEurope. Key team members include Chief Technology Officer: H. S.Vp Of Hr And Business Operations: Z. W.Vp Product Marketing: S. L. T.. Explore Infervision's employee directory with LeadIQ.

What industry does Infervision belong to?

Minus sign iconPlus sign icon
Infervision operates in the Medical Equipment Manufacturing industry.

What technology does Infervision use?

Minus sign iconPlus sign icon
Infervision's tech stack includes Sensors DataAmazon CloudFrontGoogle Fonts APISnap.svgOWL CarouselWebflowHSTSOpenResty.

What is Infervision's email format?

Minus sign iconPlus sign icon
Infervision's email format typically follows the pattern of LFirst@infervision.com. Find more Infervision email formats with LeadIQ.

How much funding has Infervision raised to date?

Minus sign iconPlus sign icon
As of April 2026, Infervision has raised $140M in funding. The last funding round occurred on Jul 23, 2021 for $140M.

When was Infervision founded?

Minus sign iconPlus sign icon
Infervision was founded in 2016.

Infervision

Medical Equipment ManufacturingNew Jersey, United States51-200 Employees

Infervision is a pioneering AI medical technology company, established in 2016, with a mission to advance multidisciplinary healthcare services through artificial intelligence. Supporting healthcare providers across three critical areas—disease screening/detection to diagnosis to patient treatment and management as well as research and development—Infervision empowers medical institutions to enhance operational efficiency and patient outcomes.
 
Our comprehensive suite of AI-driven software addresses a broad spectrum of medical needs. From detecting cancers, infectious diseases, cardiovascular conditions, and cerebrovascular diseases to managing trauma and more, Infervision’s solutions are relied upon globally. With specialized modules for disease screening and diagnosis (InferRead®), interventional support and treatment (InferOperate®), patient health management (InferCare®), and medical education and research (InferScholar®, InferMatrix, InferEducate), Infervision is a trusted partner to hospitals, medical institutions, governments, healthcare professionals, and patients worldwide.
 
We also actively engage in academic research, maintaining deep collaborations with leading institutions in radiology and medical technology. Our partnerships span over 1000 of the top hospitals across North America, Europe, and Asia, forming a sophisticated AI computing and precision healthcare intelligence system. These collaborations bridge the gap between medical data, technology, and real-world healthcare applications. This solidifies our position as a global leader in medical AI innovation and advancing the fields of medical imaging for diagnosis and treatments.

Section iconCompany Overview

Headquarters
1099 Wall Street West Lyndhurst, New Jersey 07071 United States
NAICS Code
3391 - Medical Equipment and Supplies Manufacturing
Founded
2016
Employees
51-200

Section iconFunding & Financials

  • $140M

    Infervision has raised a total of $140M of funding over 6 rounds. Their latest funding round was raised on Jul 23, 2021 in the amount of $140M.

  • $10M$25M

    Infervision's revenue is estimated to be in the range of $10M$25M

Section iconFunding & Financials

  • $140M

    Infervision has raised a total of $140M of funding over 6 rounds. Their latest funding round was raised on Jul 23, 2021 in the amount of $140M.

  • $10M$25M

    Infervision's revenue is estimated to be in the range of $10M$25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.